BackYungjin Pharm. , Ltd. Overview

Yungjin Pharm. , Ltd. Receivables

Track Yungjin Pharm. , Ltd.'s receivables ($44B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$44.26B
↓ 3.11% YoYΔ $-1.42B vs prior year quarter

Peer trimmed avg / median

Loading

Yungjin Pharm. , Ltd. Receivables History

Loading

Yungjin Pharm. , Ltd. vs. peers: Receivables Comparison

Loading

Yungjin Pharm. , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Yungjin Pharm. , Ltd. (003520.KS) FAQ

Yungjin Pharm. , Ltd.'s receivables stands at $44B as of June 2026. That compares with $46B in the prior-year period — down 3.1% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Yungjin Pharm. , Ltd. reported $44B in receivables versus $46B a year earlier — a 3.1% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $46B in the prior-year period — down 3.1% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Yungjin Pharm. , Ltd.'s receivables evolved across reporting periods, while the comparison chart places 003520.KS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.